InvestorsHub Logo
icon url

OTCdoc

12/26/15 8:47 PM

#3036 RE: OTCdoc #3035

EBITDA 1.1B & reduction in guidance - This presentation was released before the market opened on Thursday and the stock was up 10%, so clearly the market received new guidance (and cash projections) positively.

Lowered guidance was primarily due to the project sales to JPM and a general slowdown to preserve capital. Axiom is just trying to make headlines to preserve their self-interest. The market wanted SUNE to do slow down development to save cash.

SUNE is now doing what the street asked and all of this should be considered positive.

icon url

OTCdoc

12/26/15 9:02 PM

#3037 RE: OTCdoc #3035

DUE to EBITDA this stocks valuation is going much higher.